Drug Database
Back to search

Belgium· BE-AMP-SAM479173-00

Farydak 10 mg

A panobinostat product containing panobinostat lactate anhydrous, registered in Belgium by pharmaand. The same ATC class is registered in 10 of our 19 countries.

ATC L01XH03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedFarydak 10 mgATCL01XH03REGISTER NO.BE-AMP-SAM479173-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about panobinostat lactate anhydrousAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Panobinostat is registered in 10 of 19 countries.

Countries holding a registration under ATC L01XH03 (panobinostat), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search panobinostat products by name

Panobinostat · ATC L01XH03

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Panobinostat Lactate Anhydrous
Manufacturer
pharmaand
Country
Belgium (BE)
ATC code
L01XH03
ATC class
Panobinostat
Defined daily dose
5.7 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7717507
  • be_apb
    3433745

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

586 interactions on record for panobinostat.

Graded by severity as the source publishes them — 388 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check panobinostat against other medicinesHow interaction checks work

Panobinostat · interactions on record

586 records

  • 388 severe
  • 193 moderate
  • 5 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Panobinostat in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All panobinostat products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Farydak
  • Liechtenstein · Farydak
  • Norway · Farydak

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e3f335e7-0889-4bd1-96ac-4808bdb67693
GET /v1/drugs/e3f335e7-0889-4bd1-96ac-4808bdb67693?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Farydak 10 mg",
  "name_fr": "Farydak 10 mg",
  "name_nl": "Farydak 10 mg",
  "amp_code": "SAM479173-00",
  "strengths": [
    "10.0000",
    "10.0000",
    "10.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Panobinostat Lactate Anhydrous",
    "Panobinostat",
    "Mannitol",
    "Propylene Glycol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Panobinostat",
  "authorisation_numbers": [
    "EU/1/15/1023/001",
    "EU/1/15/1023/003",
    "EU/1/15/1023/002"
  ]
}
API referenceMCP serverPlans

See everything about panobinostat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console